The bipartisan legislation put forward this week would also allow off-campus hospital outpatient departments currently under construction to continue receiving higher rates than similar facilities that aren’t owned by hospitals. Bipartisan legislation introduced this week would tweak Medicare’s readmissions program to adjust for socio-economic status of patients. It would also allow off-campus hospital outpatient departments… Read More
Early reports on data form 2012 and 2013 show that plans that entered the program did better if they entered earlier rather than later. However the results are clearly mixed. From the NEJM article. In the Medicare Shared Savings Program (MSSP) — the largest of the Medicare accountable care organization (ACO) programs — participating provider… Read More
Medical coverage is one thing but physicians and patients alike will tell you coverage does not mean that they will have access to timely medical care. The issue that California is facing is that the Accountable Care Act (ACA) has covered a tremendous number of patients with Medi-Cal leading many to believe they will have… Read More
Real Estate. Internet companies. Real estate again. Banks. Next healthcare?It is interesting that there are some unbelievably conflicting articles about how the Obamacare Exchange Plans and Medicaid Expansion are going. On one side, there have been some studies that show the plans are efficient and cutting the cost of healthcare and even an Op=Ed… Read More
All of the best performance-enhancing drugs (PEDs) – such as anabolic steroids and erythropoietin (EPO) – have long since been banned. WADA conducts extensive drug testing to enforce its ban on prohibited substances. But there are some PEDs that WADA explicitly permits athletes to use.Three of these drugs – meldonium (Mildronate), telmisartan (Micardis) and T3… Read More
Wine has been taughted as having many health benefits. An article in the August 22, 2016 issue of Frontiers in Human Neuroscience suggests that smelling wine may ’sharpen your memory. In the study, researchers from the Cleveland Clinic and Université du Québec à Trois-Rivières reviewed MRI data and health data from wine sommeliers. According to… Read More
There is something wrong when companies can purchase another company’s product, limit competition, and jack up the price. Normally, one would say that is good business. But healthcare is not your usual business. Adding fuel to the fire, it appears the FDA did not approve two EPi-PEN competitors earlier in 2016 over non-safety issues. This… Read More
